To study the comparative clinical effect of Anutaila pratimarsha nasya with shirisha avaleha and Bhastrika pranayam with jalaneti in Patients of Vataja Pratishyaaya (Allergic rhinitis)

A COMPARATIVE STUDY OF ANUTAILA PRATIMARSHA NASYA WITH SHIRISHA AVALEHA AND BHASTRIKA PRANAYAMA WITH JALANETI IN VATAJA PRATISHYAYA W.S.R ALLERGIC RHINITTIS â?? AN OPEN LABELED RANDOMISED CLINICAL TRIAL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039190

Enrollment

100

Registered

2022-01-05

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J308- Other allergic rhinitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age group 16 to 50 years irrespective of their sex. 2.Patients having 4 or more diagnostic symptoms of Vataja Pratishyaya i.e. I. Kshavathu (sneezing) II. Nasasrava (rhinorrhea) III.Nasauparodha (nasa blockage) IV. Mukhashosha (dry mouth) V. Shirashoola (headache) VI. Nasaâ??bru kandu (itchy nose â??eyebrow) for a minimum of one year immediately preceding the study-Screening Visit.

Exclusion criteria

Exclusion criteria: 1. Patients having lower respiratory tract infection. 2. Upper Respiratory complaints such as Nasal polyposis, Nasal tumours. 3. Patients with adenotonsillar hypertrophy, craniofacial syndromes, or neuromuscular diseases. 4. Patients with history of nasal surgery. 5. Other respiratory infectious conditions such as Tuberculosis, Pleural effusion, Emphysema, Lung abscess, Bronchiectasis, Pneumonia, Pleurisy. 6. Congenital anomalies of respiratory tract or rhinitis due to trauma. 7. Patients suffering from chronic debilitating diseases like HIV, Hepatitis B, immune compromised etc.

Design outcomes

Primary

Measure	Time frame
1. Reduction in the severity of cardinal feature of Vataja Pratisyaya w.r.t allergic rhinitis.Timepoint: 2nd,4th, 6th and 8th week	—

Secondary

Measure	Time frame
1. Decrease in the nasal smear eosinophil count and IgE level. 2. Improvement in Average Daily Subject Reported AM and PM Reflective Total Nasal Symptom Scores (rTNSS) Over 0 â?? 4 weeks Treatment Period .[Time Frame: 0-4 weeks]. 3. Improvement in in Average Daily Subject-reported AM and PM Reflective Total Ocular Symptom Scores (rTOSS) Over the 0 â?? 4 week Treatment Period. [Time Frame: Weeks 0 - 4] Timepoint: 0 weeks, 4 weeks	—

Measure

Time frame

1. Decrease in the nasal smear eosinophil count and IgE level. 2. Improvement in Average Daily Subject Reported AM and PM Reflective Total Nasal Symptom Scores (rTNSS) Over 0 â?? 4 weeks Treatment Period .[Time Frame: 0-4 weeks]. 3. Improvement in in Average Daily Subject-reported AM and PM Reflective Total Ocular Symptom Scores (rTOSS) Over the 0 â?? 4 week Treatment Period. [Time Frame: Weeks 0 - 4] Timepoint: 0 weeks, 4 weeks

—

Countries

India

Contacts

Public ContactDr Pankaj Kundal

All India Institute of Ayurveda, Gautampuri Sarita Vihar, New delhi

hod-shalakya@aiia.gov.in9560788850

Outcome results